Health technology assessment of colorectal cancer chemotherapy with afl ibercept
Colorectal cancer (CRC) is an actual medical problem of the Russian Health Care system due to high morbidity and mortality rates. Despite the arrival of newer anti-cancer agents in the second-line setting for CRC treatment during the last years, no Health Technology Assessments (HTA) were preformed...
Main Authors: | A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-05-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/109 |
Similar Items
-
Assessment of the economic evaluation of the contrast agent Iomeron in percutaneous coronary intervention
by: A. S. Kolbin, et al.
Published: (2018-06-01) -
Assessment of the economic evaluation of the contrast agent MultiHance
by: A. S. Kolbin, et al.
Published: (2018-06-01) -
Оксалиплатин в химиотерапии рака толстой кишки: клиникоэкономический анализ
Published: (2018-06-01) -
Оценка эффективности затрат на терапию второй линии неоперабельного немелкоклеточного рака лёгкого гефитинибом
Published: (2018-06-01) -
Гефитиниб для лечения немелкоклеточного рака лёгкого: анализ экономической эффективности во второй линии терапии
Published: (2018-06-01)